The blood preparation market size has grown strongly in recent years. It will grow from $51.13 billion in 2025 to $54.47 billion in 2026 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to increasing blood donation programs, expansion of hospital transfusion services, rising trauma and surgical cases, improvements in blood testing protocols, growth of centralized blood banks.
The blood preparation market size is expected to see strong growth in the next few years. It will grow to $71.08 billion in 2030 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to increasing demand for safe blood supply, rising investments in blood processing automation, expansion of component separation technologies, growing emphasis on transfusion safety, integration of digital blood management systems. Major trends in the forecast period include increasing automation of blood collection and processing, rising demand for component-based transfusions, expansion of advanced blood storage systems, growing focus on donor screening and traceability, enhanced cold chain management.
The growing number of blood donations worldwide is expected to drive the expansion of the blood preparation market in the coming years. Blood donation is the process of giving blood to help save the lives of others. It enables blood transfusions, which are critical life-sustaining and life-saving treatments. Patients need blood for surgeries, cancer treatments, chronic illnesses, and traumatic injuries. It supports transfusions during the blood preparation process, ensuring that blood is available whenever and wherever it is needed. For example, in June 2024, according to China's National Health Commission, a government agency responsible for public health policy and healthcare administration, voluntary blood donations in China reached a record 16.99 million in 2023, marking a 5.9% increase compared to 2022 and reflecting the continued strengthening of the national blood supply system. Consequently, the rise in blood donations is fueling the growth of the blood preparation market.
Major companies operating in the blood preparation market are concentrating on product innovation, such as multiplex testing, which enables simultaneous analysis of multiple blood group antigens and antibody screenings in a single well. Multiplex testing is a laboratory technique that allows several tests to be conducted at once on a single sample, detecting or measuring multiple targets in parallel, thereby saving time and sample volume. For example, in June 2024, Innobiochips SAS, a France-based biotechnology company, launched Omnys, an advanced blood grouping and testing solution aimed at improving the accuracy and efficiency of blood transfusion procedures, reflecting ongoing trends of automation and precision in blood preparation. The company also provides multiplex testing platforms and integrated software solutions.
In March 2023, Werfen, a Spain-based company specializing in diagnostics and medical equipment manufacturing, acquired Immucor, Inc. for an undisclosed amount. Through this acquisition, Werfen seeks to expand its diagnostics portfolio by incorporating Immucor’s transfusion and transplant product lines, enhancing its position in the blood preparation and transfusion diagnostics market while extending its global presence in specialized diagnostics. Immucor, Inc. is a U.S.-based transfusion and transplant diagnostics company recognized for its in vitro diagnostics solutions that support patient-donor compatibility in blood transfusion and transplantation.
Major companies operating in the blood preparation market are AstraZeneca PLC, Sanofi, LEO Pharma A/S, Bristol-Myers Squibb Company, Baxter International Inc, Pfizer Inc, Portola Pharmaceuticals Inc, GlaxoSmithKline PLC, Bayer AG, Boehringer Ingelheim, Celgene Corp, Shandong East Chemical Industry Co., Xiamen Hisunny Chemical Co. LTD, Merck & Co., Amgen Inc., Takeda Pharmaceutical Company Limited, Novartis AG, Johnson & Johnson, Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., AbbVie Inc., Roche Holding AG, CSL Behring, BioMarin Pharmaceutical Inc., Genentech Inc., Sandoz International GmbH, Medtronic plc, Fresenius Kabi AG, Grifols S.A., HemaCare Corporation, Terumo Corporation.
North America was the largest region in the blood preparation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global blood preparation market during the forecast period. The regions covered in the blood preparation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the blood preparation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the blood preparation market by increasing costs of imported centrifuges, storage freezers, testing reagents, and automated processing equipment. Blood banks and hospitals in North America and Europe are most affected due to reliance on imported blood handling technologies, while Asia-Pacific faces cost pressure on equipment procurement. These tariffs are increasing capital investment requirements and operational costs. However, they are also supporting domestic equipment manufacturing, regional supply chain development, and improved self-reliance in blood preparation infrastructure.
The blood preparation market research report is one of a series of new reports that provides blood preparation market statistics, including blood preparation industry global market size, regional shares, competitors with a blood preparation market share, detailed blood preparation market segments, market trends and opportunities, and any further data you may need to thrive in the blood preparation industry. This blood preparation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Blood preparation is the process of collecting, processing, and storing blood and its components for use in transfusions or other medical treatments. This process includes donor screening, blood collection, testing, storage, and transfusion.
The main categories of blood preparation products are whole blood, blood components, and blood derivatives. Whole blood is blood that has not been separated into its individual components, such as red blood cells, white blood cells, and plasma. It contains various antithrombotic and anticoagulant substances, including platelet aggregation inhibitors, fibrinolytics, and anticoagulants, which are used in transfusions, diagnostics, and research. The primary end-users include hospitals, clinics, blood banks, and other healthcare facilities.
The blood preparation market consists of revenues earned by entities by providing services such as blood processing, blood storing, and distributing blood and blood components for transfusion services. The market value includes the value of related goods sold by the service provider or included within the service offering. The blood preparation market also includes sales of red cells, platelets, cryoprecipitated AHF (CRYO), and granulocytes, which are used in providing blood preparation services. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The blood preparation market size is expected to see strong growth in the next few years. It will grow to $71.08 billion in 2030 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to increasing demand for safe blood supply, rising investments in blood processing automation, expansion of component separation technologies, growing emphasis on transfusion safety, integration of digital blood management systems. Major trends in the forecast period include increasing automation of blood collection and processing, rising demand for component-based transfusions, expansion of advanced blood storage systems, growing focus on donor screening and traceability, enhanced cold chain management.
The growing number of blood donations worldwide is expected to drive the expansion of the blood preparation market in the coming years. Blood donation is the process of giving blood to help save the lives of others. It enables blood transfusions, which are critical life-sustaining and life-saving treatments. Patients need blood for surgeries, cancer treatments, chronic illnesses, and traumatic injuries. It supports transfusions during the blood preparation process, ensuring that blood is available whenever and wherever it is needed. For example, in June 2024, according to China's National Health Commission, a government agency responsible for public health policy and healthcare administration, voluntary blood donations in China reached a record 16.99 million in 2023, marking a 5.9% increase compared to 2022 and reflecting the continued strengthening of the national blood supply system. Consequently, the rise in blood donations is fueling the growth of the blood preparation market.
Major companies operating in the blood preparation market are concentrating on product innovation, such as multiplex testing, which enables simultaneous analysis of multiple blood group antigens and antibody screenings in a single well. Multiplex testing is a laboratory technique that allows several tests to be conducted at once on a single sample, detecting or measuring multiple targets in parallel, thereby saving time and sample volume. For example, in June 2024, Innobiochips SAS, a France-based biotechnology company, launched Omnys, an advanced blood grouping and testing solution aimed at improving the accuracy and efficiency of blood transfusion procedures, reflecting ongoing trends of automation and precision in blood preparation. The company also provides multiplex testing platforms and integrated software solutions.
In March 2023, Werfen, a Spain-based company specializing in diagnostics and medical equipment manufacturing, acquired Immucor, Inc. for an undisclosed amount. Through this acquisition, Werfen seeks to expand its diagnostics portfolio by incorporating Immucor’s transfusion and transplant product lines, enhancing its position in the blood preparation and transfusion diagnostics market while extending its global presence in specialized diagnostics. Immucor, Inc. is a U.S.-based transfusion and transplant diagnostics company recognized for its in vitro diagnostics solutions that support patient-donor compatibility in blood transfusion and transplantation.
Major companies operating in the blood preparation market are AstraZeneca PLC, Sanofi, LEO Pharma A/S, Bristol-Myers Squibb Company, Baxter International Inc, Pfizer Inc, Portola Pharmaceuticals Inc, GlaxoSmithKline PLC, Bayer AG, Boehringer Ingelheim, Celgene Corp, Shandong East Chemical Industry Co., Xiamen Hisunny Chemical Co. LTD, Merck & Co., Amgen Inc., Takeda Pharmaceutical Company Limited, Novartis AG, Johnson & Johnson, Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., AbbVie Inc., Roche Holding AG, CSL Behring, BioMarin Pharmaceutical Inc., Genentech Inc., Sandoz International GmbH, Medtronic plc, Fresenius Kabi AG, Grifols S.A., HemaCare Corporation, Terumo Corporation.
North America was the largest region in the blood preparation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global blood preparation market during the forecast period. The regions covered in the blood preparation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the blood preparation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the blood preparation market by increasing costs of imported centrifuges, storage freezers, testing reagents, and automated processing equipment. Blood banks and hospitals in North America and Europe are most affected due to reliance on imported blood handling technologies, while Asia-Pacific faces cost pressure on equipment procurement. These tariffs are increasing capital investment requirements and operational costs. However, they are also supporting domestic equipment manufacturing, regional supply chain development, and improved self-reliance in blood preparation infrastructure.
The blood preparation market research report is one of a series of new reports that provides blood preparation market statistics, including blood preparation industry global market size, regional shares, competitors with a blood preparation market share, detailed blood preparation market segments, market trends and opportunities, and any further data you may need to thrive in the blood preparation industry. This blood preparation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Blood preparation is the process of collecting, processing, and storing blood and its components for use in transfusions or other medical treatments. This process includes donor screening, blood collection, testing, storage, and transfusion.
The main categories of blood preparation products are whole blood, blood components, and blood derivatives. Whole blood is blood that has not been separated into its individual components, such as red blood cells, white blood cells, and plasma. It contains various antithrombotic and anticoagulant substances, including platelet aggregation inhibitors, fibrinolytics, and anticoagulants, which are used in transfusions, diagnostics, and research. The primary end-users include hospitals, clinics, blood banks, and other healthcare facilities.
The blood preparation market consists of revenues earned by entities by providing services such as blood processing, blood storing, and distributing blood and blood components for transfusion services. The market value includes the value of related goods sold by the service provider or included within the service offering. The blood preparation market also includes sales of red cells, platelets, cryoprecipitated AHF (CRYO), and granulocytes, which are used in providing blood preparation services. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Blood Preparation Market Characteristics
3. Blood Preparation Market Supply Chain Analysis
4. Global Blood Preparation Market Trends and Strategies
5. Blood Preparation Market Analysis of End Use Industries
7. Global Blood Preparation Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Blood Preparation Total Addressable Market (TAM) Analysis for the Market
9. Blood Preparation Market Segmentation
10. Blood Preparation Market Regional and Country Analysis
11. Asia-Pacific Blood Preparation Market
12. China Blood Preparation Market
13. India Blood Preparation Market
14. Japan Blood Preparation Market
15. Australia Blood Preparation Market
16. Indonesia Blood Preparation Market
17. South Korea Blood Preparation Market
18. Taiwan Blood Preparation Market
19. South East Asia Blood Preparation Market
20. Western Europe Blood Preparation Market
21. UK Blood Preparation Market
22. Germany Blood Preparation Market
23. France Blood Preparation Market
24. Italy Blood Preparation Market
25. Spain Blood Preparation Market
26. Eastern Europe Blood Preparation Market
27. Russia Blood Preparation Market
28. North America Blood Preparation Market
29. USA Blood Preparation Market
30. Canada Blood Preparation Market
31. South America Blood Preparation Market
32. Brazil Blood Preparation Market
33. Middle East Blood Preparation Market
34. Africa Blood Preparation Market
36. Blood Preparation Market Competitive Landscape and Company Profiles
37. Blood Preparation Market Other Major and Innovative Companies
40. Blood Preparation Market High Potential Countries, Segments and Strategies
41. Appendix
Executive Summary
Blood Preparation Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses blood preparation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for blood preparation? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The blood preparation market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Whole Blood; Blood Components; Blood Derivatives2) By Antithrombotic And Anticoagulants Type: Platelet Aggregation Inhibitors; Fibrinolytics; Anticoagulants
3) By Application: Transfusion; Diagnostics; Research
4) By End User: Hospitals; Clinics; Blood Banks; Other End-Users
Subsegments:
1) By Whole Blood: Fresh Whole Blood; Stored Whole Blood2) By Blood Components: Red Blood Cells (RBC); Platelets; Plasma; White Blood Cells (WBC)
3) By Blood Derivatives: Immunoglobulins; Coagulation Factors; Albumin; Fibrinogen
Companies Mentioned: AstraZeneca PLC; Sanofi; LEO Pharma A/S; Bristol-Myers Squibb Company; Baxter International Inc; Pfizer Inc; Portola Pharmaceuticals Inc; GlaxoSmithKline PLC; Bayer AG; Boehringer Ingelheim; Celgene Corp; Shandong East Chemical Industry Co.; Xiamen Hisunny Chemical Co. LTD; Merck & Co.; Amgen Inc.; Takeda Pharmaceutical Company Limited; Novartis AG; Johnson & Johnson; Gilead Sciences Inc.; Regeneron Pharmaceuticals Inc.; AbbVie Inc.; Roche Holding AG; CSL Behring; BioMarin Pharmaceutical Inc.; Genentech Inc.; Sandoz International GmbH; Medtronic plc; Fresenius Kabi AG; Grifols S.A.; HemaCare Corporation; Terumo Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Blood Preparation market report include:- AstraZeneca PLC
- Sanofi
- LEO Pharma A/S
- Bristol-Myers Squibb Company
- Baxter International Inc
- Pfizer Inc
- Portola Pharmaceuticals Inc
- GlaxoSmithKline PLC
- Bayer AG
- Boehringer Ingelheim
- Celgene Corp
- Shandong East Chemical Industry Co.
- Xiamen Hisunny Chemical Co. LTD
- Merck & Co.
- Amgen Inc.
- Takeda Pharmaceutical Company Limited
- Novartis AG
- Johnson & Johnson
- Gilead Sciences Inc.
- Regeneron Pharmaceuticals Inc.
- AbbVie Inc.
- Roche Holding AG
- CSL Behring
- BioMarin Pharmaceutical Inc.
- Genentech Inc.
- Sandoz International GmbH
- Medtronic plc
- Fresenius Kabi AG
- Grifols S.A.
- HemaCare Corporation
- Terumo Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 54.47 Billion |
| Forecasted Market Value ( USD | $ 71.08 Billion |
| Compound Annual Growth Rate | 6.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 32 |
